APP announced that it will launch Imipenem and Cilastatin for Injection and Meropenem for Injection, generic versions of Primaxin IV (Merck) and Merrem IV (AstraZeneca), respectively. It is ...

Meropenem (Penem 500mg Injection) is a carbapenem antibiotic, prescribed for bacterial infections like skin and skin structure infections, bacterial meningitis, serious nosocomial infections like ...

June 2, 2005 — The U.S. Food and Drug Administration (FDA) has approved extended-release dexmethylphenidate HCl capsules for once-daily treatment of attention deficit/hyperactivity disorder in adults, ...

Drug firm Aurobindo Pharma has received final approval from the US health regulator for Meropenem injection used for treatment of complicated skin and related infections, complicated intra abdominal ...

Review the side-effects of Meropenem as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "Carbapenem Market Size, Share & Trends Analysis Report By Drug Class (Meropenem, Imipenem, Ertapenem), By Application (UTI, Blood Stream Infections, ...

Share price of Aurobindo Pharma rose 2 percent intraday Tuesday on USFDA approval for Meropenem Injection. The company has received final approval from the US Food & Drug Administration (USFDA) to ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, ...

New Delhi, Mar 28 (PTI) Drug firm Aurobindo Pharma has received final approval from the US health regulator for Meropenem injection used for treatment of complicated skin and related infections, ...

"The approved product has an estimated market size of USD 118 million for the 12-month ending January 2017, according to IMS," said Aurobindo Pharma. The company "has received final approval from the ...